FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:787-789 September 11, 1997 Number 11 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Healy, B. Related Article by Struewing, J. P. Related Article by Schrag, D.

To the Editor: The report by Schrag and colleagues (May 15 issue)¹ is of epidemiologic interest but of no great clinical use to women at risk for carrying BRCA1 or BRCA2 mutations or to the physicians caring for them. The results are presented to demonstrate the average effect of prophylactic surgery in a population of women at risk. For a woman at risk for breast or ovarian cancer, the development of the disease is an all-or-none phenomenon. The study is lacking in that the data are not presented in such a way that one can estimate the degree of risk . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.